Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04315246 |
|---|---|
| Brief Title: | 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma) |
| First Submitted : | March 12, 2020 |
| First Submitted that Met QC Criteria : | March 16, 2020 |
| First Posted : | March 19, 2020 |
| Last Update Submitted that Met QC Criteria : | July 12, 2022 |
| Last Update Posted : | July 15, 2022 |